Topical miconazole is not considered a cause of miscarriage. One study did find a small increased risk, but that study had significant methodological problems, and other studies have not confirmed the finding. Miconazole applied vaginally or to the skin is, in fact, the type of antifungal treatment most often recommended during pregnancy.
What the Research Shows
The concern about miconazole and miscarriage traces back to a single study that suggested a slight increase in risk. However, researchers identified several flaws in that study’s design that may have skewed the results. Multiple other studies looking at the same question have not found a connection between miconazole use and pregnancy loss.
One important reason topical miconazole is considered low-risk: very little of it enters your bloodstream. When miconazole is applied vaginally, the average systemic absorption is only about 1.4%. That means nearly 99% of the medication stays local, treating the infection without reaching the rest of your body or your developing pregnancy in any meaningful amount.
Topical vs. Oral Antifungals in Pregnancy
The clearer risk during pregnancy comes from oral antifungal medications, not topical ones. A large study comparing oral fluconazole (the pill form commonly sold as Diflucan) to topical treatments like miconazole found that oral fluconazole carried a 62% higher rate of spontaneous abortion. Out of 2,823 pregnancies exposed to oral fluconazole in early pregnancy, 130 ended in miscarriage, compared to 118 out of 2,823 pregnancies treated with topical antifungals.
This is exactly why topical azole creams and suppositories, including miconazole, are the standard recommendation for treating yeast infections during pregnancy. They treat the infection effectively while keeping drug exposure almost entirely local.
How Miconazole Is Used During Pregnancy
Yeast infections are more common during pregnancy because hormonal changes alter the vaginal environment. When treatment is needed, a 7-day course of a topical antifungal like miconazole is the standard approach. Shorter treatment courses (1-day or 3-day) are more likely to fail during pregnancy, so the longer duration is recommended for better results.
Some providers suggest inserting vaginal suppositories by hand rather than using the plastic applicator that comes in the box, since the applicator could theoretically irritate the cervix. This varies by provider preference, so it’s worth asking about if you’re uncertain.
The FDA Classification
Miconazole has been classified as Pregnancy Category C by the FDA. This means animal studies using very high oral doses (28 to 45 times the maximum possible exposure from topical use, assuming every bit were absorbed) showed some effects on pregnancy outcomes in rats and rabbits. But those doses bear no resemblance to what reaches your system from a vaginal cream or suppository, where absorption is under 2%.
Category C essentially means there aren’t large, controlled human trials proving absolute safety, which is true of most medications because those trials are rarely conducted in pregnant women for ethical reasons. It does not mean the drug is known to be harmful. In practice, topical miconazole has decades of widespread use during pregnancy and remains the treatment providers reach for first.
What Actually Matters for Safety
If you’re pregnant and dealing with a yeast infection, the key takeaways are straightforward. Topical miconazole (creams, suppositories, or ointments) is the preferred treatment and has not been reliably linked to miscarriage. Oral antifungal pills carry a documented higher risk and should be avoided in early pregnancy. A 7-day treatment course works better than shorter options during pregnancy. And leaving a yeast infection untreated isn’t necessary, since the discomfort is real and the standard treatment is considered safe.